Liver Profile of Atazanavir/Ritonavir in Pregnant Albino Rats

Elias Adikwu, James Kemelayefa, Winifred Ocheiga

Abstract


Medication use during pregnancy is challenging due to the occurrence of maternal or fetal toxicities. Atazanavir/ritonavir (ATV/r) has hepatotoxic potential hence; use in pregnant patients living with human immunodeficiency virus may cause maternal hepatotoxicity. This study assessed the liver profile of ATV/r in pregnant albino rats. Thirty pregnant albino rats randomized into groups were orally treated daily with ATV/r (4.28/1.43 mg/kg-34.3/11.4 mg/kg) for 16 days. After treatment, the rats were weighed and sacrificed. Blood samples were collected and examined for serum biochemical parameters. Liver samples were weighed and assessed for biochemical and histological changes. Body and liver weights were normal (p>0.05) in ATV/r-treated pregnant rats when compared to control. Serum total cholesterol, triglyceride, low density lipoprotein cholesterol and blood glucose levels were significantly (p<0.01) elevated whereas high density lipoprotein cholesterol level was significantly (p<0.01) decreased in rats treated with ATV/r (34.3/11.4 mg/kg) when compared to control. Liver and serum aminotransferases, alkaline phosphatase, gamma-glutamyl transferase, lactate dehydrogenase, total bilirubin, and conjugated bilirubin levels were significantly increased in a dose-dependent fashion in rats treated with ATV/r; 8.57/2.86 mg/kg (p<0.05), 17.1/5.72 mg/kg (p<0.01) and 34.3/11.4 mg/kg (p<0.001) when compared to control. Liver superoxide dismutase, catalase, glutathione and glutathione peroxidase levels were significantly decreased whereas malondialdehyde levels were significantly increased in a dose-dependent fashion in rats treated with ATV/r; 8.57/2.86 mg/kg (p<0.05), 17.1/5.72 mg/kg (p<0.01) and 34.3/11.4 mg/kg (p<0.001) when compared to control. Necrotic hepatocytes were observed at higher doses of ATV/r. ATV/r may not be hepatotoxic in pregnant women living with HIV at the clinical dose.

Keywords


Atazanavir/ritonavir; pregnancy; liver; toxicity; rats

Full Text:

PDF

References


Abdol–Karim Q, AbouZahr C, Dehne K, Mangiaterra V, Moodley J, Rollins N, Say L, e tal (2010). HIV and maternal mortality: turning point. Lancet,375:1948-1949

Abduljalil K, Furness P, Johnson TN, Rostami-Hodjegan A, Soltani H. (2012). Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling. Clin Pharm, 51: 365–396

Achenbach CJ, Darin KM Murphy RL Katlama C. (2011) Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults Fut Virol. 6(2): 157–177

Ehigiator EB and Adikwu E. (2019) Ethanolic Extract of Chrysophyllum albidum Stem Bark Prevents Alloxan-Induced Diabetes Not Sci Biol, 11(3):325-331

Aebi H,Catalase in vitro,” in Method in Enzymology, S. P. Colowick and N. O. Kaplane, Eds., Academic Press, New York, NY, USA. 1984

Bera E, Naidoo D, Williams M. (2012) Maternal deaths following nevirapinebased antiretroviral therapy S Afr J HIV Med,13(4):196-197.

Buege JA, Aust SD. (1978) Microsomal lipid peroxidation. Methods Enzymol, 52: 302-310.

Clark R. Sex (2005) Differences in antiretroviral therapy-associated intolerance and adverse events. Drug Saf, 28: 1075-1083.

Clayden P. (2009). Safety of antiretroviral in pregnancy, South Afric Jour HIV Med. 15-19

Conradie F, Zorrilla IC, Josipovic D, Botes M, Osiyemi O, Vandeloise E et al. (2011). Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women HIV Med ,12: 570–579

Coovadia HM, Rollins NC, Bland RM, Little K,Coutsoudis A, Bennish ML, et al. (2007) Mother-to child transmission of HIV-1 infection duringexclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet, 31; 369(9567):1107-16.

Eholié SP, Lacombe K, Serfaty L, Wendum D, Girard PM. (2004). Acute hepatic cytolysis in an HIV-infected patient taking atazanavir. AIDS, 18: 1610-1

Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD et al. (2010) Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos, 38(5):833-840.

Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18(6):499- 502.

Gornall A. G, Bardawill C. J. and David M. M. (1949). Determination of serum proteins by means of the biureto reaction.J. Biol. Chem., 177, 751-766.

Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine. New York: Oxford University Press; 1999; pp. 1–350.

Hamada Y, Nishijima T, Watanabe K et al. (2012) High incidence of renal stones among hiv-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy, Clinic Infect Dis. 55: 1262–1269.

Hammoud, G. M. and Ibdah, J. A. (2014). Preeclampsia-induced Liver Dysfunction, HELLP syndrome, and acute fatty liver of pregnancy. Clin Liver Dis, 4: 69–73.

Janero DR. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free RadicBiol Med. 19:515-540.

Joshi D, James, A, Quaglia, A Westbrook, R et al. (2010) Liver disease in pregnancy, 375: 9714; 594–605

Joy S, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, et al. (2005). Third-trimester maternal toxicity with nevirapine use in pregnancy Obstet Gynecol, 106: 1032-1038.

Kim KA, Lee WK, Kim JK, Seo MS, Lim Y, Lee Y, et al. (2001). Mechanism of refractory ceramic bre- and rock wool induced cytotoxicity in alveolar macrophages. Int Arch Occup Environ Health, 74:9–15

Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HJ. (2014). Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations Hepatology. 59(2): 661–670

Lee WM. (1995). Drug-induced hepatotoxicity. NEngl J Med, 333:1118-27.

Mandelbrot L, Mazy f, Floch-Tudal C, et al. (2011) Atazanavir in Pregnancy: impact on neonatal hyperbilirubinaemia. Eur J Obstet Gynecol Reprod Biol, 157: 18-21

Navarro VJ and Senior JR. (2006) Drug-Related Hepatotoxicity. N Eng J Med,354: 731-739

Rosen HR, Keefe EB. (2000). Evaluation of abnormal liver enzymes,use of liver tests and the serology of viral hepatitis: Liverdisease, diagnosis and management. 1st ed. New York; Churchilllivingstone publishers, 24-35

Rotruck JT, Rope AL, Ganther HF, Swason AB. (1997). Selenium: biochemical role as a component of glutathione peroxidase. Sci. 179: 588–90.

Sedlak, J, Lindsay RH. (1986). Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem, 25: 192-205.

Singh B, Saxena AK, Chandan BK, Anand KK, Suri OP, Suri K (1989). Hepatoprotective activity of verbenalin on experimental liver damage in rodents. Fit. 69:135–140.

Sultan S (2014). Reviewing the Protective Role of Antioxidants in Oxidative Stress Caused by Free Radicals Asian Pac. J. Health Sci., 1(4): 401-406

Sun M, Zigma S. (1978). An improved spectrophotometer assay of superoxide dismutase based on epinephrine antioxidation. Anal Biochem. 90: 81–89.

von Hentig N, Dauer B, Haberl A, Klauke S, Lutz T, et al. (2007). Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavirboosted atazanavir in HIV-1-infected adults. Eur J Clin Pharmacol. 63: 935-940.

Wooley, A. Determination—General and reproductive toxicology. In: A Guide to Practical Toxicology Evaluation, Prediction and Risk, 2003, pp. 80–106. Taylor and Francis, New York

YinY, Xu L, and Porter NA. (2011). Free radical lipid peroxidation: mechanisms and analysis Chem Rev, 111; 10; 5944–5972




DOI: https://doi.org/10.14421/biomedich.2019.82.47-52

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Elias Adikwu, James Kemelayefa, Winifred Ocheiga



Biology, Medicine, & Natural Product Chemistry
ISSN 2089-6514 (paper) - ISSN 2540-9328 (online)
Published by Sunan Kalijaga State Islamic University & Society for Indonesian Biodiversity.

Creative Commons License
This work is licensed under a CC BY-NC